ABVC BioPharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $-922.8K | $106.4K |
| Jun 2017 | — | $-1.0M | $8.1K |
| Sep 2017 | — | $-1.4M | $204.9K |
| Dec 2017 | — | $-1.8M | $350.3K |
| Mar 2018 | — | $-1.9M | $174.4K |
| Jun 2018 | — | $-2.2M | $309.3K |
| Sep 2018 | — | $-2.4M | $4.4K |
| Dec 2018 | — | $-5.7M | $226.7K |
| Mar 2019 | — | $-5.8M | $981.3K |
| Jun 2019 | — | $-3.3M | $540.3K |
| Sep 2019 | — | $665.9K | $1.0M |
| Dec 2019 | — | $-151.0K | $144.3K |
| Mar 2020 | — | $-1.1M | $123.6K |
| Jun 2020 | $124.4K | $-1.1M | $390.2K |
| Sep 2020 | $124.4K | $-536.4K | $135.7K |
| Dec 2020 | — | $3.4M | $4.3M |
| Mar 2021 | — | $2.6M | $2.6M |
| Jun 2021 | — | $1.4M | $924.8K |
| Sep 2021 | — | $8.6M | $3.7M |
| Dec 2021 | — | $8.8M | $5.8M |
| Mar 2022 | — | $7.4M | $2.7M |
| Jun 2022 | — | $9.3M | $2.9M |
| Sep 2022 | — | $5.9M | $1.3M |
| Dec 2022 | — | $3.1M | $85.3K |
| Mar 2023 | — | $1.7M | $1.1M |
| Jun 2023 | — | $-379.3K | $99.3K |
| Sep 2023 | — | $9.1M | $500.1K |
| Dec 2023 | — | $1.6M | $60.2K |
| Mar 2024 | — | $1.7M | $30.5K |
| Jun 2024 | — | $1.8M | $124.3K |
| Sep 2024 | — | $1.6M | $137.3K |
| Dec 2024 | — | $1.2M | $248.4K |
| Mar 2025 | — | $5.4M | $152.2K |
| Jun 2025 | — | $7.0M | $388.3K |
| Sep 2025 | — | $12.1M | $192.1K |
| Dec 2025 | — | $11.1M | $681.5K |
| Mar 2026 | — | $10.8M | $140.3K |
| Jun 2026 | — | $10.3M | $31.9K |